10:03 AM EDT, 04/21/2026 (MT Newswires) -- James Edgemond, CFO and Treasurer, on April 20, 2026, sold 10,000 shares in United Therapeutics ( UTHR ) for $5,778,607. Following the Form 4 filing with the SEC, Edgemond has control over a total of 18,876 common shares of the company, with 18,876 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000163617826000011/xslF345X05/primarydocument.xml

Price: 566.26, Change: -7.19, Percent Change: -1.25